BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28331547)

  • 1. Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma.
    Koczkowska M; Lipska-Ziętkiewicz BS; Iliszko M; Ryś J; Miettinen M; Lasota J; Biernat W; Harazin-Lechowska A; Kruczak A; Limon J
    Mol Cytogenet; 2017; 10():7. PubMed ID: 28331547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of
    Rekhi B; Karnik N; Agrawal R; Shetty O; Patkar S
    Indian J Pathol Microbiol; 2022; 65(1):65-75. PubMed ID: 35074968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
    Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
    Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in recurrence and survival of extremity liposarcoma subtypes.
    Vos M; Koseła-Paterczyk H; Rutkowski P; van Leenders GJLH; Normantowicz M; Lecyk A; Sleijfer S; Verhoef C; Grünhagen DJ
    Eur J Surg Oncol; 2018 Sep; 44(9):1391-1397. PubMed ID: 29673808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
    Cho J; Lee SE; Choi YL
    Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
    Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
    BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization.
    Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
    Genes Chromosomes Cancer; 1996 Feb; 15(2):89-94. PubMed ID: 8834171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
    Lu J; Wood D; Ingley E; Koks S; Wong D
    Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
    Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
    Mod Pathol; 2024 Apr; 37(6):100494. PubMed ID: 38621503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
    Peng T; Zhang P; Liu J; Nguyen T; Bolshakov S; Belousov R; Young ED; Wang X; Brewer K; López-Terrada DH; Oliveira AM; Lazar AJ; Lev D
    Lab Invest; 2011 Mar; 91(3):392-403. PubMed ID: 21060307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
    Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gains of 13q are correlated with a poor prognosis in liposarcoma.
    Schmidt H; Bartel F; Kappler M; Würl P; Lange H; Bache M; Holzhausen HJ; Taubert H
    Mod Pathol; 2005 May; 18(5):638-44. PubMed ID: 15540119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.
    Keung EZ; Akdemir KC; Al Sannaa GA; Garnett J; Lev D; Torres KE; Lazar AJ; Rai K; Chin L
    J Clin Invest; 2015 Aug; 125(8):2965-78. PubMed ID: 26193637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenomic Characterization of Giant Ring or Rod Marker Chromosome in Four Cases of Well-Differentiated and Dedifferentiated Liposarcoma.
    Chai H; Xu F; DiAdamo A; Grommisch B; Mao H; Li P
    Case Rep Genet; 2022; 2022():6341207. PubMed ID: 35450197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma.
    Thirasastr P; Somaiah N
    Ther Adv Med Oncol; 2022; 14():17588359221081073. PubMed ID: 35251319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms.
    Kyriazoglou A; Pagkali A; Kotsantis I; Economopoulou P; Kyrkasiadou M; Moutafi M; Gavrielatou N; Anastasiou M; Boulouta A; Pantazopoulos A; Giannakakou M; Digklia A; Psyrri A
    Cancer Treat Rev; 2024 Apr; 125():102716. PubMed ID: 38492514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.